Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodality Adaptive Intervention for Post-Inpatient Hospitalization Suicide Risk Reduction

NCT06764108 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06764108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06764108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodality Adaptive Intervention for Post-Inpatient Hospitalization Suicide Risk Reduction
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
January 31, 2030
Enrollment
360 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal behavior, suicidal ideation